Old Web
English
Sign In
Acemap
>
authorDetail
>
Nicolaj Frost
Nicolaj Frost
Humboldt University of Berlin
Internal medicine
Pembrolizumab
Radiation therapy
Medicine
concurrent chemoradiation
3
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
KEYNOTE-799: Phase 2 trial of pembrolizumab plus platinum chemotherapy and radiotherapy for unresectable, locally advanced, stage 3 NSCLC.
2021
Journal of Clinical Oncology
Salma K. Jabbour
Ki Hyeong Lee
Nicolaj Frost
Valeriy Breder
Dariusz M. Kowalski
Issam Abdelkarim Alawin
Evgeny Levchenko
Noemi Reguart
Alex Martinez Marti
Baerin Houghton
Jean Baptiste Paoli
Sufia Safina
Keunchil Park
Takefumi Komiya
Amy Sanford
Vishal Boolell
Hong Liu
Ayman Samkari
Steven M. Keller
Martin Reck
Show All
Source
Cite
Save
Citations (1)
Phase II study of pembrolizumab (pembro) plus platinum doublet chemotherapy and radiotherapy as first-line therapy for unresectable, locally advanced stage III NSCLC: KEYNOTE-799.
2020
Journal of Clinical Oncology
Salma K. Jabbour
Ki Hyeong Lee
Nicolaj Frost
Dariusz M. Kowalski
V V Breder
Theodore Pollock
Noemi Reguart
Baerin Houghton
Xavier Quantin
Steven M. Keller
Hong Liu
Bilal Piperdi
Martin Reck
Show All
Source
Cite
Save
Citations (11)
1